STOCK TITAN

II-VI Incorporated Reports Fiscal 2020 Fourth Quarter and Full Year Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

II-VI reported record quarterly revenues of $746.2 million for the fourth quarter of FY20, with a significant backlog of $957 million. The company achieved a GAAP operating income of $67.4 million and a non-GAAP EPS of $1.18. Full year cash flow from operations reached a record $297.3 million, and free cash flow totaled $160.4 million. Following a successful equity raise, the net debt leverage ratio improved from 3.8 to 2.0, strengthening the company’s financial fundamentals and positioning it for future growth.

Positive
  • Record quarterly revenue of $746.2 million, up from $627.0 million sequentially.
  • GAAP operating income of $67.4 million and non-GAAP operating income of $124.6 million.
  • Record cash flow from operations of $297.3 million and free cash flow of $160.4 million.
  • Improved net debt leverage ratio from 3.8 to 2.0 post-equity raise.
  • Strong backlog of $957 million, indicating future revenue potential.
Negative
  • GAAP operating margin decreased to 9.0% from 11.0% sequentially.
  • Achieves Record Quarterly Revenues of $746.2M and Backlog of $957M
  • Quarterly GAAP Operating Income of $67.4M and Non-GAAP Operating Income of $124.6M
  • Quarterly GAAP EPS of $0.53 and Non-GAAP EPS of $1.18
  • Record Full Year Cash Flow from Operations of $297.3M
  • Record Full Year Free Cash1 Flow of $160.4M
  • The Company’s early July FY21 equity raise improved its net debt leverage ratio2 from 3.8 to 2.0

PITTSBURGH, Aug. 13, 2020 (GLOBE NEWSWIRE) -- II-VI Incorporated (Nasdaq:IIVI) ("II-VI," “We” or the "Company") today reported results for its fiscal 2020 fourth quarter and fiscal year ended June 30, 2020.

“In the fourth quarter, we remained and continue to remain vigilant and steadfast in ensuring the health and safety of our global workforce while striving to meet our customers' growing expectations despite the continuation and acceleration of COVID-19. We also made great progress against our key business initiatives. The power of our vertically integrated and geographically diverse footprint and business model, allowed our employees to deliver exceptional results, including record revenues and backlog,” said Dr. Vincent D. (Chuck) Mattera, Jr. “I am very pleased with the Finisar integration which continues ahead of expectations, as we accelerated our component strategy and are on track to exceed our first year synergy cost savings goals. Demand in the 3D-Sensing and communications market remains strong as the digital transformation continues, led by continued growth of 5G deployment and network infrastructure upgrades.”

Dr. Mattera continued, “Our financial fundamentals are strong. We achieved record cash flow from operations, undertook a very successful equity raise and delivered free cash flow at about $150M above the acquisition business case. Our cash balance now stands at $493M, an increase of $105M from the previous quarter, and our post-equity raise leverage ratio2 is approximately 2.0, down from 3.8 at March 31, 2020. Our backlog of just under $1.0B provides us with significant momentum as we enter fiscal year 2021.”

1 Free cash flow of $160.4M is defined as cash flow from operations of $297.3M less capital expenditures of $136.9M.
2 Reflects the July 2020 activity in which the Company used the net proceeds from the July 2020 equity raise to repay the remaining balance of $715 million under the Company’s Term B Loan Facility. The net debt leverage ratio is calculated in accordance with the terms of the Credit Agreement.

Table 1 
Financial Metrics           
$ Millions, except per share amounts and %       
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020  2020  2019   2020 2019 
            
Revenues $746.2  $627.0  $362.7   $2,380.0  $1,362.4 
            
GAAP Gross Profit $302.2  $245.9  $138.7   $819.6  $521.3 
Non-GAAP Gross Profit (2) $315.7  $235.5  $139.5   $912.4  $524.5 
            
GAAP Operating Income (Loss) (1) $67.4  $69.0  $40.7   $39.5  $148.7 
Non-GAAP Operating Income (2) $124.6  $81.6  $56.9   $324.8  $209.7 
            
GAAP Net Earnings (Loss) $51.3  $5.9  $28.0   $(67.0) $107.5 
Non-GAAP Net Earnings (2) $117.8  $39.2  $42.6   $258.6  $158.2 
            
GAAP Diluted Earnings (Loss) Per Share $0.53  $0.06  $0.43   $(0.79) $1.63 
Non-GAAP Diluted Earnings Per Share (2) $1.18  $0.42  $0.65   $2.85  $2.40 
              
Other Selected Financial Metrics           
GAAP Gross margin 40.5% 39.2% 38.2%   34.4% 38.3%
Non-GAAP gross margin (2) 42.3% 37.6% 38.5%   38.3% 38.5%
GAAP Operating margin 9.0% 11.0% 11.2%   1.7% 10.9%
Non-GAAP operating margin (2) 16.7% 13.0% 15.7%   13.6% 15.4%
GAAP Return on sales 6.9% 0.9% 7.7%   -2.8% 7.9%
Non-GAAP return on sales (2) 15.8% 6.3% 11.7%   10.9% 11.6%

(1) GAAP Operating income (loss) is defined as earnings (loss) before income taxes, interest expense and other expense or income, net.

(2) All non-GAAP amounts exclude certain adjustments for share-based compensation, acquired intangible amortization expense, certain one-time transaction expenses, fair value measurement period adjustments and restructuring and related items. See Table 4 for the Reconciliation of GAAP measures to non-GAAP measures.

Outlook

The outlook for the first fiscal 2021 quarter ending September 30, 2020 is revenue of $700 million to $750 million and earnings per diluted share on a non-GAAP basis of $0.45 to $0.60. These are at today’s exchange rate and today’s estimated tax impact of 25%, both of which are subject to variability. The non-GAAP earnings per share include the pre-tax amounts of $20.6 million in amortization, $20.3 million in share-based compensation, $23.6 million in debt extinguishment costs related to our July 2020 equity raise, and $5.0 million in other costs, including costs to facilitate the integration. Non-GAAP adjustments are by their nature highly volatile and we have low visibility as to the range that may be incurred in the future.

Conference Call & Webcast Information

The Company will host a conference call at 9:00 a.m. Eastern Time on Thursday, August 13, 2020 to discuss these results. Individuals wishing to participate in the webcast can access the event at the Company’s web site by visiting www.ii-vi.com or via https://tinyurl.com/IIVIQ4FY20Earnings. If you wish to participate in the conference call, please dial +1 (877) 316-5288 for calls from the U.S. and +1 (734) 385-4977 for calls from outside the U.S. To join the conference call, please enter ID# 1259279, then provide your name and company affiliation.

The conference call will be recorded, and a replay will be available to interested parties who are unable to attend the live call. This service will be available until 11:59 p.m. Eastern Time on Friday, August 14, 2020, by dialing +1 (855) 859-2056 for calls from the U.S. and +1 (404) 537-3406 for calls from outside the U.S., and entering ID# 1259279. 

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, U.S.A., the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

Forward-looking Statements

This press release contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties, which could cause actual results, performance or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures.

The Company believes that all forward-looking statements made by it in this release have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to: (i) the failure of any one or more of the assumptions stated above to prove to be correct; (ii) the risks relating to forward-looking statements and other “Risk Factors” discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 and the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended September 30, 2019, December 31, 2019 and March 31, 2020; (iii) the purchasing patterns of customers and end-users; (iv) the timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the Company’s ability to assimilate recently acquired businesses, and risks, costs and uncertainties associated with such acquisitions; (vii) the Company’s ability to devise and execute strategies to respond to market conditions; and/or (viii) the risks of business and economic disruption related to the currently ongoing COVID-19 outbreak and any other worldwide health epidemics and outbreaks that may arise.  The Company disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events or developments, or otherwise.

Use of Non-GAAP Financial Measures

The Company has disclosed financial measurements in this press release that present financial information considered to be non-GAAP financial measures. These measurements are not a substitute for GAAP measurements, although the Company's management uses these measurements as an aid in monitoring the Company's on-going financial performance. The non-GAAP net earnings, the non-GAAP earnings per share, the non-GAAP operating income, the non-GAAP gross profit, the non-GAAP internal research and development, the non-GAAP selling, general and administration, the non-GAAP interest and other (income) expense, and the non-GAAP income tax (benefit), measure earnings and operating income (loss), respectively, excluding non-recurring or unusual items that are considered by management to be outside the Company’s standard operation and excluding certain non-cash items. EBITDA is an adjusted non-GAAP financial measurement that is considered by management to be useful in measuring the profitability between companies within the industry by reflecting operating results of the Company excluding non-operating factors. There are limitations associated with the use of non-GAAP financial measures, including that such measures may not be entirely comparable to similarly titled measures used by other companies, due to potential differences among calculation methodologies. Thus, there can be no assurance whether (i) items excluded from the non-GAAP financial measures will occur in the future or (ii) there will be cash costs associated with items excluded from the non-GAAP financial measures. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by providing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with GAAP.



II-VI Incorporated and Subsidiaries
Condensed Consolidated Statements of Earnings (Loss) (Unaudited)
($000 except per share data)
       
  Three Months Ended
  June 30, March 31, June 30,
  2020 2020 2019
       
Revenues $746,290  $627,041  $362,728 
       
Costs, Expenses & Other Expense (Income)      
Cost of goods sold 444,153  381,108  224,076 
Internal research and development 100,489  94,764  36,202 
Selling, general and administrative 134,152  82,133  61,731 
Interest expense 25,521  28,530  5,606 
Other expense (income), net 1,264  7,168  384 
Total Costs, Expenses, & Other Expense (Income) 705,579  593,703  327,999 
       
Earnings Before Income Taxes 40,711  33,338  34,729 
       
Income Taxes (10,550 27,417  6,701 
       
Net Earnings $51,261  $5,921  $28,028 
       
Diluted Earnings Per Share $0.53  $0.06  $0.43 
       
Basic Earnings Per Share $0.56  $0.07  $0.44 
       
Average Shares Outstanding  - Diluted 102,142  93,435  65,887 
Average Shares Outstanding  - Basic 91,517  91,081  63,719 


II-VI Incorporated and Subsidiaries
Condensed Consolidated Statements of Earnings (Loss) (Unaudited)
($000 except per share data)
     
  Year Ended
  June 30, June 30,
  2020 2019
     
Revenues $2,380,071  $1,362,496 
     
Costs, Expenses & Other Expense (Income)    
Cost of goods sold 1,560,521  841,147 
Internal research and development 339,073  139,163 
Selling, general and administrative 440,998  233,518 
Interest expense 89,409  22,417 
Other expense (income), net 13,998  (2,562)
Total Costs, Expenses, & Other Expense (Income) 2,443,999  1,233,683 
     
Earnings (Loss) Before Income Taxes (63,928) 128,813 
     
Income Taxes 3,101  21,296 
     
Net Earnings (Loss) $(67,029) $107,517 
     
Diluted Earnings (Loss) Per Share $(0.79) $1.63 
     
Basic Earnings (Loss) Per Share $(0.79) $1.69 
     
Average Shares Outstanding  - Diluted 84,828  65,804 
Average Shares Outstanding  - Basic 84,828  63,584 


II-VI Incorporated and Subsidiaries    
Condensed Consolidated Balance Sheets (Unaudited)    
($000)      
     
  June 30, June 30,
  2020 2019
Assets    
Current Assets    
Cash and cash equivalents $493,046  $204,872 
Accounts receivable 598,124  269,642 
Inventories 619,810  296,282 
Prepaid and refundable income taxes 12,279  11,778 
Prepaid and other current assets 65,710  30,337 
Total Current Assets 1,788,969  812,911 
Property, plant & equipment, net 1,214,772  582,790 
Goodwill 1,239,009  319,778 
Other intangible assets, net 758,368  139,324 
Investments 73,767  76,208 
Deferred income taxes 22,938  8,524 
Other assets 136,891  14,238 
Total Assets $5,234,714  $1,953,773 
     
Liabilities and Shareholders’ Equity    
Current Liabilities    
Current portion of long-term debt $69,250  $23,834 
Accounts payable 268,773  104,462 
Operating lease current liabilities 24,634   
Accruals and other current liabilities 310,236  142,267 
Total Current Liabilities 672,893  270,563 
Long-term debt 2,186,092  443,163 
Deferred income taxes 45,551  23,913 
Operating lease liabilities 94,701   
Other liabilities 158,674  82,925 
Total Liabilities 3,157,911  820,564 
Total Shareholders' Equity 2,076,803  1,133,209 
Total Liabilities and Shareholders’ Equity $5,234,714  $1,953,773 


II-VI Incorporated and Subsidiaries    
Condensed Consolidated Statements of Cash Flows (Unaudited)    
($000)   Year Ended
  June 30,
  2020 2019
Cash Flows from Operating Activities    
Net cash provided by operating activities $297,292  $178,475 
     
Cash Flows from Investing Activities    
Additions to property, plant & equipment (136,877) (137,122)
Purchases of businesses, net of cash acquired (1,036,609) (83,067)
Purchases of technology intangible assets (3,750)  
Purchase of equity investments and other investing activities (2,054) (3,787)
Net cash used in investing activities (1,179,290) (223,976)
     
Cash Flows from Financing Activities    
Proceeds from borrowings of Term A Facility 1,241,000   
Proceeds from borrowings of Term B Facility 720,000   
Procedures from borrowings of Revolving Credit Facility 160,000   
Proceeds from borrowings under prior Credit Facility 10,000  150,000 
Payment on Finisar Notes (560,112)  
Payments on borrowings under prior Term Loan, Credit Facility, and other loans (176,618) (135,000)
Payments on borrowings under Term A Facility (46,538)  
Payments on borrowings under Term B Facility (5,400)  
Payments on borrowings under Revolving Credit Facility (86,000)  
Debt issuance costs (63,510) (5,589)
Proceeds from exercises of stock options 13,467  8,698 
Common stock repurchase (1,625) (1,616)
Payments in satisfaction of employees' minimum tax obligations (28,700) (7,092)
Other financing activities (2,339) (4,524)
Net cash provided by financing activities 1,173,625  4,877 
     
Effect of exchange rate changes on cash and cash equivalents (3,453) (1,542)
Net increase (decrease) in cash and cash equivalents 288,174  (42,166)
Cash and Cash Equivalents at Beginning of Period 204,872  247,038 
Cash and Cash Equivalents at End of Period $493,046  $204,872 




Table 2           
Segment Revenues, GAAP Operating Income (Loss) & Margins, and        
Non-GAAP Operating Income (Loss) & Margins*       
$ Millions, except %           
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020  2020  2019   2020  2019 
Revenues:           
Photonic Solutions $517.2   $417.7   $177.5    $1,536.7   $638.8  
Compound Semiconductors 229.0   209.3   185.2    821.2   723.6  
Unallocated and Other           22.1     
Consolidated $746.2   $627.0   $362.7    $2,380.0   $1,362.4  
            
GAAP Operating Income (Loss):           
Photonic Solutions $49.1   $48.7   $22.2    $49.9   $81.9  
Compound Semiconductors 19.6   24.9   23.1    62.3   82.4  
Unallocated and Other (1.3)  (4.6)  (4.6)   (72.7)  (15.6) 
Consolidated $67.4   $69.0   $40.7    $39.5   $148.7  
            
Non-GAAP Operating Income (Loss):           
Photonic Solutions $88.8   $54.2   $28.2    $224.4   $106.6  
Compound Semiconductors 35.8   27.4   28.7    100.6   103.1  
Unallocated and Other           (0.2)    
Consolidated $124.6   $81.6   $56.9    $324.8   $209.7  
            
GAAP Operating Margin:           
Photonic Solutions 9.5% 11.7% 12.5%  3.2% 12.8%
Compound Semiconductors 8.6% 11.9% 12.5%  7.6% 11.4%
Unallocated and Other NA  NA  NA   NA  NA 
Consolidated 9.0% 11.0% 11.2%  1.7% 10.9%
            
Non-GAAP Operating Margin:           
Photonic Solutions 17.2% 13.0% 15.9%  14.6% 16.7%
Compound Semiconductors 15.6% 13.1% 15.5%  12.3% 14.2%
Unallocated and Other NA  NA  NA   NA  NA 
Consolidated 16.7% 13.0% 15.7%  13.6% 15.4%

* During the three months ended June 30, 2020 and March 31, 2020 and the year ended June 30, 2020, “Unallocated and Other” primarily includes continuing transaction costs related to the Finisar acquisition.  Finisar results have been consolidated into the Photonic Solutions and Compound Semiconductors segments during the three months ended June 30, 2020 and March 31, 2020 and for the year ended June 30, 2020.   See Table 3 for the reconciliation of segment non-GAAP operating income (loss) to segment GAAP operating income (loss).



Table 3           
Reconciliation of Segment Non-GAAP Operating Income (Loss) to        
GAAP Segment Operating Income (Loss)           
$ Millions           
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020 2020 2019  2020 2019
Non-GAAP Photonic Solutions Operating Income $88.8   $54.2   $28.2    $224.4   $106.6  
Measurement period adjustment on long-lived assets (1.9)  10.2            
Share-based compensation (17.9)  (9.6)  (3.6)   (43.0)  (12.0) 
Amortization of acquired intangibles (15.9)  (6.1)  (2.4)   (53.3)  (9.3) 
Fair value adjustment on acquired inventory           (74.2)    
Restructuring and related expenses (4.0)         (4.0)    
Transaction expenses related to acquisitions              (3.4) 
Photonic Solutions GAAP Operating Income $49.1   $48.7   $22.2    $49.9   $81.9  
            
Non-GAAP Compound Semiconductors Operating Income $35.8   $27.4   $28.7    $100.6   $103.1  
Measurement period adjustment on long-lived assets (7.2)  3.2            
Share-based compensation (6.1)  (4.8)  (3.2)   (20.1)  (13.0) 
Amortization of acquired intangibles (2.9)  0.4   (2.2)   (8.9)  (7.3) 
Restructuring and related expenses    (1.3)      (2.9)    
Transaction expenses related to acquisitions       (0.2)      (0.4) 
Fair value adjustment on acquired inventory           (6.4)    
Compound Semiconductors GAAP Operating Income $19.6   $24.9   $23.1    $62.3   $82.4  
            
Non-GAAP Unallocated and Other Operating Income (Loss) $   $   $    $(0.2)  $  
Finisar results           1.9     
Transaction expenses related to acquisitions (1.3)  (2.9)  (4.6)   (17.8)  (15.6) 
Severance and related - Share-based compensation           (10.7)   
Severance and related - Other compensation    (1.7)      (10.0)    
Amortization of acquired intangibles           (2.0)   
Preliminary fair value adjustment on acquired inventory           (7.1)    
One-time costs related to the Finisar acquisition           (26.8)   
Unallocated and Other GAAP Operating Income (Loss) $(1.3)  $(4.6)  $(4.6)   $(72.7)  $(15.6) 
            
Total GAAP Operating Income $67.4   $69.0   $40.7    $39.5   $148.7  
            
Non-GAAP Operating Income $124.6   $81.6   $56.9    $324.8   $209.7  
            

*Amounts may not recalculate due to rounding.



Table 4           
Reconciliation of GAAP Measures to non-GAAP Measures           
$ Millions           
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020 2020 2019  2020 2019
Gross profit on GAAP basis $302.2   $245.9   $138.7    $819.6   $521.3  
Finisar results (5)           (6.5)    
Share-based compensation (2) 4.4   3.0   0.8    11.6   3.2  
Fair value adjustment on acquired inventory (1)           87.7     
Measurement period adjustment on long-lived assets (6) (8) 9.1   (13.4)           
Gross profit on non-GAAP basis $315.7   $235.5   $139.5    $912.4   $524.5  
            
Internal research and development on GAAP basis $100.5   $94.8   $36.2    $339.1   $139.2  
Share-based compensation (2) (6.1)  (4.2)      (16.2)    
Finisar results (5)           (2.9)    
Severance, restructuring and related costs (4) (3.5)         (3.5)    
Internal research and development on non-GAAP basis $90.9   $90.6   $36.2    $316.5   $139.2  
            
Selling, general and administrative on GAAP basis $134.2   $82.1   $61.7    $441.0   $233.5  
Share-based compensation (2) (13.5)  (7.2)  (6.0)   (35.3)  (21.8) 
Transaction expenses related to acquisitions (3) (1.3)  (2.9)  (4.8)   (44.6)  (19.4) 
Finisar results (5)           (1.7)    
Severance, restructuring and related costs (4) (0.5)  (3.0)      (24.1)    
Amortization of acquired intangibles (18.8)  (5.7)  (4.6)   (64.2)  (16.6) 
Selling, general and administrative on non-GAAP basis $100.2   $63.4   $46.3    $271.2   $175.7  
            
Operating income on GAAP basis $67.5   $69.0   $40.7    $39.5   $148.7  
Finisar results (5)           (1.9)    
Share-based compensation (2) 24.0   14.4   6.8    63.1   25.0  
Fair value adjustment on acquired inventory (1)           87.7     
Amortization of acquired intangibles 18.8   5.7   4.6    64.2   16.6  
Measurement period adjustment on long-lived assets (6) (8) 9.1   (13.4)           
Severance, restructuring and related costs (4) 4.0   3.0       27.6     
Transaction expenses related to acquisitions (3) 1.3   2.9   4.8    44.6   19.4  
Operating income on non-GAAP basis $124.6   $81.6   $56.9    $324.8   $209.7  
            


Table 4           
Reconciliation of GAAP Measures to non-GAAP Measures (Continued)       
$ Millions           
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020 2020 2019  2020 2019
Interest and other (income) expense, net on GAAP basis $26.8   $35.7   $6.0    $103.4   $19.9  
Finisar results (5)           0.3     
Foreign currency exchange losses, net (8) (6.3)  (3.5)  (2.3)   (14.4)  (3.2) 
Additional interest expense related to Finisar acquisition (5)           (1.7)    
Impairment of investment (7)    (5.0)      (5.0)    
Debt extinguishment expense (5)           (3.9)    
Interest and other (income) expense, net on non-GAAP basis $20.5   $27.2   $3.7    $78.7   $16.7  
            
Income taxes (benefit) on GAAP basis $(10.6  $27.4   $6.7    $3.1   $21.3  
Tax impact of non-GAAP measures (8) (2.6)  (3.2)  3.9    (15.1
)  13.5  
Tax impact of fair value adjustments (8) (9) (0.4)  (9.0)           
Income taxes (benefit) on non-GAAP basis $(13.6)  $15.2   $10.6    $(12.0
)  $34.8  
            
Net earnings (loss) on GAAP basis $51.3   $5.9   $28.0    $(67.0)  $107.5  
Finisar results (5)           (1.6)    
Share-based compensation (2) 24.0   14.4   6.8    63.1   25.0  
Fair value adjustment on acquired inventory (1)           87.7     
Amortization of acquired intangibles 18.8   5.7   4.6    64.2   16.6  
Measurement period adjustment on long-lived assets (6) (8) 9.1   (13.4)           
Transaction expenses related to acquisitions (3) 1.3   2.9   4.8    44.6   19.4  
Severance, restructuring and related costs (4) 4.0   3.0       27.6     
Foreign currency exchange losses, net (8) 6.3   3.5   2.3    14.4   3.2  
Additional interest expense related to Finisar acquisition (5)           1.7     
Impairment of investment (7)    5.0       5.0     
Debt extinguishment expense (5)           3.9     
Tax impact of non-GAAP measures and fair value adjustments (8) (9) 3.0   12.2   (3.9)   15.1   (13.5) 
Net earnings on non-GAAP basis $117.8   $39.2   $42.6    $258.6   $158.2  
            
Per share data:           
Net earnings (loss) on GAAP basis           
Diluted Earnings (Loss) Per Share (10) $0.53   $0.06   $0.43    $(0.79)  $1.63  
Basic Earnings (Loss) Per Share $0.56   $0.07   $0.44    $(0.79)  $1.69  
            
Net earnings on non-GAAP basis           
Diluted Earnings Per Share (10) (11) $1.18   $0.42   $0.65    $2.85
   $2.40  
Basic Earnings Per Share $1.32   $0.43   $0.67    $3.05
   $2.49  

*Amounts may not recalculate due to rounding.

  1. The preliminary fair value adjustment of $87.7 million represents the preliminary step up value adjustment of acquired inventory from the Finisar acquisition.
  2. Total share-based compensation expense for the year ended June 30, 2020 was $63.1 million, of which $10.7 million was incurred in relation to severance related expenses as described below in note 4.
  3. Transaction costs primarily represent acquisition and integration costs related to the Finisar acquisition.
  4. In connection with the acquisition of Finisar, the Company recorded $20.6 million of compensation in the Condensed Consolidated Statement of Earnings (Loss), of which $18.1 million was associated with Finisar’s executive severance and retention agreements. Included in this amount is $10.7 million of share-based compensation. Restructuring and related costs include $6.9 million of ongoing expenses to achieve the Company’s cost synergy strategy.
  5. “Finisar results” includes the consolidated Finisar operations for the period between the acquisition date of September 24, 2019 and September 30, 2019, which includes additional interest expense and debt extinguishment expense as a result of the acquisition financing.  Finisar results have been consolidated into the Photonic Solutions and Compound Semiconductors segments during the three months ended June 30, 2020 and March 31, 2020.
  6. Represents the depreciation impact of measurement period adjustments to the fair value of long-lived assets acquired in the Finisar acquisition.
  7. Represents an impairment charge of an investment for which the carrying value was determined to be unrecoverable.
  8. The non-GAAP financial measures for the comparative periods presented above have been adjusted to conform to the current period presentation.
  9. Includes the tax impact of measurement period adjustments to the fair value of long-lived and intangible assets acquired in the Finisar acquisition.
  10. For purposes of calculating GAAP and Non-GAAP diluted earnings per share for the three months ended June 30, 2020, the Company applied the if-converted method to account for the Company’s convertible debt.  In performing this calculation, approximately $2.8 million of convertible debt interest was added to the numerator and approximately 7.3 million shares were added to the denominator.
  11. For purposes of calculation Non-GAAP diluted earnings per share for the twelve months ended June 30, 2020, the Company applied the if-converted method to account for the Company’s convertible debt.  In performing this calculation approximately $11.3 million of convertible debt interest was added to the numerator, and 7.3 million shares were added to the denominator.  In addition, approximately 2.4 million shares were added to the denominator for common stock equivalents.



Table 5           
Reconciliation of GAAP Net Income (Loss), EBITDA and Adjusted EBITDA       
$ Millions           
(Unaudited) Three Months Ended  Year Ended
  Jun 30, Mar 31, Jun 30,  Jun 30, Jun 30,
  2020 2020 2019  2020 2019
Net earnings (loss) on GAAP basis $51.3  $5.9  $28.0   $(67.0)  $107.5 
Income taxes (benefit) (10.6 27.5  6.7   3.1   21.3 
Depreciation and amortization 73.8  38.0  24.8   220.9   92.4 
Interest expense 25.5  28.6  5.6   89.4   22.4 
EBITDA (1) $140.0  $100.0  $65.1   $246.4   $243.6 
EBITDA margin 18.8 % 15.9 % 17.9 %  10.4  % 17.9 %
            
Preliminary fair value adjustment on acquired inventory        87.7    
Share-based compensation 24.0  14.4  6.8   63.1   25.0 
Transaction expenses related to other acquisitions 1.3  2.9  4.8   44.6   19.4 
Foreign currency exchange losses, net 6.3  3.5  2.3   14.4   3.2 
Severance, restructuring and related costs 4.0  4.6     27.6    
Impairment of investment   5.0     5.0    
Special items - Other income (expense), net        4.3    
Adjusted EBITDA (2) $175.6  $130.4  $79.0   $493.1   $291.2 
Adjusted EBITDA margin 23.5 % 20.8 % 21.8 %  20.7  % 21.4 %

*Amounts may not recalculate due to rounding.

(1) EBITDA is defined as earnings before interest, income taxes, depreciation and amortization.

(2) Adjusted EBITDA excludes non-GAAP adjustments for share-based compensation, acquired intangibles amortization expense, certain one-time transaction expense, the impact of restructuring and related items, investment impairment charge and the impact of foreign currency exchange gains and losses.

Mary Jane Raymond
Treasurer and Chief Financial Officer
investor.relations@ii-vi.com
www.ii-vi.com/contact-us 


FAQ

What were II-VI's quarterly earnings for Q4 FY20?

II-VI reported quarterly earnings of $746.2 million in revenue and a GAAP EPS of $0.53.

What is II-VI's outlook for the first fiscal 2021 quarter?

II-VI expects revenue between $700 million and $750 million, with non-GAAP EPS estimated between $0.45 and $0.60.

How much free cash flow did II-VI generate in FY20?

II-VI generated free cash flow of $160.4 million in fiscal year 2020.

What is II-VI's net debt leverage ratio after the equity raise?

After the July 2020 equity raise, II-VI's net debt leverage ratio improved from 3.8 to 2.0.

What were II-VI's full year revenues for FY20?

II-VI reported full year revenues of $2.38 billion for fiscal year 2020.

IIVI

NYSE:IIVI

IIVI Rankings

IIVI Latest News

IIVI Stock Data

2.30M
Optical Instrument and Lens Manufacturing
Manufacturing
Link
US
Saxonburg